Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (GHK-Cu)

FDA explains that compounded injectable drugs containing GHK-Cu may pose immunogenicity risks due to aggregation and peptide-related impurities.

Not legal or medical advice.

This page is for informational purposes only. Always verify the current official source or consult a qualified professional before making compliance, prescribing, purchasing, or clinical decisions. Read full disclaimer.